Pharm

Hourly Subcutaneous Insulin

search

Hourly Subcutaneous Insulin, Hourly Subcutaneous Insulin Aspart, Hourly Subcutaneous Insulin Lispro

  • Contraindications
  1. Severe Diabetic Ketoacidosis (pH <7.0, serum bicarbonate <10 mmol/L)
  2. Altered Level of Consciousness (e.g. stupor or coma)
  3. Significant Electrolyte abnormalities
  • Precautions
  1. Correct Hypokalemia prior to Insulin Dosing
  2. Fluid administration is central to DKA treatment
  • Protocol
  • Adults
  1. See Diabetic Ketoacidosis Management in Adults
  2. General
    1. Use subcutaneous Rapid-Acting Insulin (Lispro, Aspart)
  3. Fluids and Electrolytes
    1. Coadminister fluids as per Diabetic Ketoacidosis
      1. Initial Intravenous Fluid bolus (1-2 L NS or LR)
      2. Maintenance fluids at 150 ml/hour
    2. Do not start Insulin until Serum Potassium is at least >3.5 mEq/L
    3. Monitor serum electolytes, Serum Ketones, and Venous Blood Gas every 4 hours
  4. Dextrose solution is added when Blood Glucose <250 mg/dl
    1. Blood Glucose 200 to 250 mg/dl: Add D5W 100 ml/h
    2. Blood Glucose 150-199 mg/dl: Add D5W 150 ml/h
    3. Blood Glucose 100-149 mg/dl: Add D5W 200 ml/h
    4. Blood Glucose <100 mg/dl: Add D5W 250 ml/h, provider notified and hold Insulin
    5. Treat Hypoglycemia (Glucose <70 mg/dl)
  5. Hourly SQ Insulin Protocol (with hourly bedside Glucose)
    1. Initial SQ bolus dose: 0.2 to 0.3 units/kg (other protocols start with 0.1 unit/kg)
    2. Next: 0.1 units/kg/hour SQ until Hyperglycemia corrects (Blood Glucose <250 mg/dl)
    3. Next: 0.05 units/kg/hour SQ until DKA resolves (Anion Gap closed to <16)
    4. Discontinue hourly dosing when Glucose 150-200
  6. Every 2 hour SQ Insulin Protocol (with every 2 hour bedside Glucose)
    1. Initial SQ bolus dose: 0.2 to 0.3 units/kg
    2. Next: 0.2 units/kg every 2 hours SQ until Hyperglycemia corrects (Blood Glucose <250 mg/dl)
    3. Next: 0.1 units/kg every 2 hours SQ until DKA resolves (Anion Gap closed to <16)
  • Protocol
  • Children
  1. See Diabetic Ketoacidosis Management in Children
  2. Precautions
    1. SQ Insulin for DKA Management is less established in children
    2. Blood Glucose every 2 hours
  3. General
    1. Use subcutaneous Rapid-Acting Insulin (Lispro, Aspart)
    2. Coadminister fluids as per Diabetic Ketoacidosis
    3. Monitor serum electolytes, Serum Ketones, and Venous Blood Gas every 4 hours
  4. Every 2 hour SQ Insulin Protocol
    1. Give 0.1 to 0.15 units/kg every 1-2 hours
    2. Decrease dosing as Hyperglycemia corrects (Blood Glucose <250 mg/dl)
  • Efficacy
  1. As effective and safe as Insulin Infusion
  2. Advantage over Insulin Infusion
    1. May be monitored on regular medical ward (non-ICU)
    2. Reduced cost by 39% compared with infusion